tiprankstipranks
Trending News
More News >
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Technical Analysis

Compare
1,692 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
3Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Beam Therapeutics’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is 0.99, suggesting Beam Therapeutics is a Sell.
Beam Therapeutics’s (BEAM) 20-Day exponential moving average is 18.94, while Beam Therapeutics’s (BEAM) share price is $21.16, making it a Buy.
Beam Therapeutics’s (BEAM) 50-Day exponential moving average is 18.61, while Beam Therapeutics’s (BEAM) share price is $21.16, making it a Buy.

Beam Therapeutics (BEAM) Pivot Points

Jul 13, 2025, 05:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.74
20.39
21.21
21.86
22.68
23.33
24.15
Fibonacci
20.39
20.95
21.30
21.86
22.42
22.77
23.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Jul 13, 2025, 05:34 AM
Period
Simple
Exponential
MA5
20.83Buy
20.86Buy
MA10
19.54Buy
19.93Buy
MA20
18.23Buy
18.94Buy
MA50
17.85Buy
18.61Buy
MA100
20.27Buy
19.91Buy
MA200
22.98Sell
22.27Sell
Beam Therapeutics’s (BEAM) 10-Day exponential moving average is 19.93, while Beam Therapeutics’s (BEAM) share price is $21.16, making it a Buy.
Beam Therapeutics’s (BEAM) 100-Day exponential moving average is 19.91, while Beam Therapeutics’s (BEAM) share price is $21.16, making it a Buy.
Beam Therapeutics’s (BEAM) stock price is $21.16 and Beam Therapeutics’s (BEAM) 50-day simple moving average is 17.85, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $21.16 and Beam Therapeutics’s (BEAM) 100-day simple moving average is 20.27, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $21.16 and Beam Therapeutics’s (BEAM) 200-day simple moving average is 22.98, creating a Sell signal.

Beam Therapeutics (BEAM) Technical Indicators

Jul 13, 2025, 05:34 AM
Name
Value
Implied Action
RSI (14)
65.49
Neutral
STOCH (9,6)
84.44
Sell
STOCHRSI (14)
85.53
Sell
MACD (12,26)
0.99
Sell
ADX (14)
21.88
Neutral
Williams %R
-21.09
Buy
CCI (14)
133.77
Sell
ATR (14)
1.26
-
Ultimate Oscillator
56.51
Neutral
ROC
26.25
Buy
Beam Therapeutics’s (BEAM) Relative Strength Index (RSI) is 65.49, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Trend Strength Indicator (ADX) is 21.88, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Commodity Channel Index (CCI) is 133.77, creating a Sell signal.
Beam Therapeutics’s (BEAM) Price Rate of Change (ROC) is 26.25, creating a Buy signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Buy.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 65.49, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is 0.99, which suggests BEAM is a Sell.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 20.83, which suggests BEAM is a Buy.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 18.23, which suggests BEAM is a Buy.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 17.85, which suggests BEAM is a Buy.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 22.98, which suggests BEAM is a Sell.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -21.09, which suggests BEAM is a Buy.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is 133.77, which suggests BEAM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis